Clinical Trial Update: The Multi-Center, Randomized, Double-blind, Positive Controlled Clinical Trial of Bicyclol in the Treatment of Acute DILI [Phase 3]

View source ↗

Summary

A multi-center, randomized Phase 3 trial evaluating bicyclol for acute drug-induced liver injury is in progress with positive-controlled design.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Liver Injury
• Liver Injury

Drugs mentioned

• Bicyclol (bicyclol)

Snippet

Sponsor: Drug Induced Liver Disease Study Group | Conditions: Drug-Induced Acute Liver Injury | Phase 3 | Status: UNKNOWN